Management of psychosis and schizophrenia in adults: summary of updated NICE guidance

  title={Management of psychosis and schizophrenia in adults: summary of updated NICE guidance},
  author={Elizabeth Kuipers and Amina Yesufu-Udechuku and Clare Taylor and Tim Kendall},
  journal={BMJ : British Medical Journal},
Psychosis is relatively common, with schizophrenia being the most prevalent form of psychotic disorder, affecting about seven in 1000 adults, with onset typically occurring between the ages of 15 and 35.1 These disorders, which are characterised by distressing hallucinations and delusions, disturbed behaviour, and memory and motivation problems, present a major personal,2 social,3 clinical,4 and financial5 challenge. Moreover, poor physical health is strongly associated with schizophrenia, with… 
Recognition and Differential Diagnosis of Psychosis in Primary Care.
Clinicians should ask about recent head injury or trauma, seizures, cerebrovascular disease, or new or worsening headaches, and a subacute onset of psychosis should raise suspicion for an oncologic cause.
A Mentalization-Informed Staging Approach to Clinical High Risk for Psychosis
This work will present the evidence suggesting that the roots of residual social functioning impairment may, in many cases, come from thwarted or arrested development in the specialization of social cognition during adolescence and early adulthood, and adapt the staging model of SSP progression in function of the mentalization-informed model.
The Case of Ramona Williams: Losing Touch
  • Renee Saenger
  • Psychology, Medicine
    Early Career Physician Mental Health and Wellness
  • 2019
The clinician should suspect a primary psychotic illness in a young early career physician who is exhibiting a reduced ability to function in his or her role, poor self-care, bizarre or erratic behaviors, irritability, and overt delusional thoughts and/or interaction with internal stimuli.
Unravelling psychosis: psychosocial epidemiology, mechanism, and meaning
This research has confirmed the role of the external social world in the development and persistence of psychotic disorder and corroborates the hypothesized role of non-psychotic symptoms in mediation, and attests to the power of the approaches described.
A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists' Interventions on Patient Outcome
The case proves that it is critical for clinical pharmacists to be involved in the multidisciplinary team during management of patients with psychosis.
Treatment of early episode in patients with schizophrenia: the role of long acting antipsychotics
Key elements to take into account when offering a LAI in the early course of schizophrenia should include their potential superiority in allowing early detection of non-adherence and in reducing the number of rehospitalisations and relapses.
Expanding Traditional Paradigms: An Integrative Approach to the Psychotherapeutic Treatment of Psychosis
The psychiatric treatment of individuals experiencing psychosis often follows the traditional medical model, focusing on symptom management, risk reduction, psychopharmacology, and stabilization.
Clinical factors related to schizophrenia relapse
Several classes of risk factors have been proved to be relevant in the risk of relapse and a careful assessment of the risk factors here identified should be performed in daily clinical practice in order to individualise the relapse risk for each patient and to provide a targeted treatment in high-risk subjects.


Long-Term Outcome of Patients with Schizophrenia: A Review
  • T. Jobe, M. Harrow
  • Psychology, Medicine
    Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 2005
The studies reviewed expose problems in clinical management and treatment and also help anticipate the possibility of intervals or periods of recovery, some of which appear spontaneously and may be tied to individual patient factors such as resilience.
The Role of Primary Care in Service Provision for People with Severe Mental Illness in the United Kingdom
Primary care is centrally involved in the care of people with serious mental illness, but primary care and cross-boundary continuity is poor for a substantial proportion of people, including contacts with primary and secondary care and continuity of care.
Twenty-five year mortality of a community cohort with schizophrenia
People with schizophrenia have a mortality risk that is two to three times that of the general population, and most of the extra deaths are from natural causes.
Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders
The life expectancy gap for people with mental disorders has somewhat diminished in the three Nordic countries and the results support further development of the Nordic welfare state model, i.e. tax-funded community-based public services and social protection.
A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
In light of the potential for second-generation antipsychotic medications to further adversely influence mortality rates in the decades to come, optimizing the general health of people with schizophrenia warrants urgent attention.
Inequalities in healthcare provision for people with severe mental illness
To tackle systemic barriers to healthcare provision integrated care models could be employed including co-location of physical and mental health services or the use of case managers or other staff to undertake a co-ordination or liaison role between services.
Physical illness and schizophrenia: a review of the literature
Objective:  The lifespan of people with schizophrenia is shortened compared to the general population. We reviewed the literature on comorbid physical diseases in schizophrenia to provide a basis for
Post-Traumatic Stress Disorder: The Management of PTSD in Adults and Children in Primary and Secondary Care
It is shown that post-traumatic stress disorder has its believers and non-believers, but the balance appears to be moving in favour of the former.
Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
The National Institute for Health and Clinical Excellence (NICE) guideline, Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary
Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence
This entry is our analysis of a review or synthesis of research findings considered particularly relevant to improving outcomes from drug or alcohol interventions in the UK. The original review was